nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—migraine—Prednisone—chronic obstructive pulmonary disease	0.469	1	CpDpCtD
Tizanidine—CYP1A2—chronic obstructive pulmonary disease	0.369	1	CbGaD
Tizanidine—Clonidine—CYP1A1—chronic obstructive pulmonary disease	0.000762	0.509	CrCbGaD
Tizanidine—Clonidine—CYP1A2—chronic obstructive pulmonary disease	0.000735	0.491	CrCbGaD
Tizanidine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000168	0.00119	CcSEcCtD
Tizanidine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000168	0.00119	CcSEcCtD
Tizanidine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00119	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00119	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00119	CcSEcCtD
Tizanidine—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00119	CcSEcCtD
Tizanidine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00118	CcSEcCtD
Tizanidine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00118	CcSEcCtD
Tizanidine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00117	CcSEcCtD
Tizanidine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000165	0.00117	CcSEcCtD
Tizanidine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.00117	CcSEcCtD
Tizanidine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00117	CcSEcCtD
Tizanidine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00117	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00116	CcSEcCtD
Tizanidine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.00116	CcSEcCtD
Tizanidine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.00116	CcSEcCtD
Tizanidine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00115	CcSEcCtD
Tizanidine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00115	CcSEcCtD
Tizanidine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00115	CcSEcCtD
Tizanidine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00115	CcSEcCtD
Tizanidine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00115	CcSEcCtD
Tizanidine—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00114	CcSEcCtD
Tizanidine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00114	CcSEcCtD
Tizanidine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00114	CcSEcCtD
Tizanidine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00113	CcSEcCtD
Tizanidine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00016	0.00113	CcSEcCtD
Tizanidine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00113	CcSEcCtD
Tizanidine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00113	CcSEcCtD
Tizanidine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00113	CcSEcCtD
Tizanidine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00113	CcSEcCtD
Tizanidine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000159	0.00112	CcSEcCtD
Tizanidine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00112	CcSEcCtD
Tizanidine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00112	CcSEcCtD
Tizanidine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00112	CcSEcCtD
Tizanidine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00112	CcSEcCtD
Tizanidine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00112	CcSEcCtD
Tizanidine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00112	CcSEcCtD
Tizanidine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00112	CcSEcCtD
Tizanidine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000157	0.00111	CcSEcCtD
Tizanidine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.00111	CcSEcCtD
Tizanidine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000157	0.00111	CcSEcCtD
Tizanidine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00111	CcSEcCtD
Tizanidine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000156	0.0011	CcSEcCtD
Tizanidine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000155	0.0011	CcSEcCtD
Tizanidine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000155	0.0011	CcSEcCtD
Tizanidine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00109	CcSEcCtD
Tizanidine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00109	CcSEcCtD
Tizanidine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00108	CcSEcCtD
Tizanidine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00108	CcSEcCtD
Tizanidine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00108	CcSEcCtD
Tizanidine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00107	CcSEcCtD
Tizanidine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00107	CcSEcCtD
Tizanidine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.00107	CcSEcCtD
Tizanidine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00107	CcSEcCtD
Tizanidine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00106	CcSEcCtD
Tizanidine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00106	CcSEcCtD
Tizanidine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00105	CcSEcCtD
Tizanidine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000148	0.00105	CcSEcCtD
Tizanidine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00105	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00105	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00105	CcSEcCtD
Tizanidine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000146	0.00103	CcSEcCtD
Tizanidine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00103	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00102	CcSEcCtD
Tizanidine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000144	0.00102	CcSEcCtD
Tizanidine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.00102	CcSEcCtD
Tizanidine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.00102	CcSEcCtD
Tizanidine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000144	0.00102	CcSEcCtD
Tizanidine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00101	CcSEcCtD
Tizanidine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00101	CcSEcCtD
Tizanidine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00101	CcSEcCtD
Tizanidine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000143	0.00101	CcSEcCtD
Tizanidine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000142	0.00101	CcSEcCtD
Tizanidine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000141	0.000999	CcSEcCtD
Tizanidine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000141	0.000997	CcSEcCtD
Tizanidine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00099	CcSEcCtD
Tizanidine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00014	0.00099	CcSEcCtD
Tizanidine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.00099	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000987	CcSEcCtD
Tizanidine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000139	0.000982	CcSEcCtD
Tizanidine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.000982	CcSEcCtD
Tizanidine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.000973	CcSEcCtD
Tizanidine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000137	0.000969	CcSEcCtD
Tizanidine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.000966	CcSEcCtD
Tizanidine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.000963	CcSEcCtD
Tizanidine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000961	CcSEcCtD
Tizanidine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000135	0.000959	CcSEcCtD
Tizanidine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000955	CcSEcCtD
Tizanidine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000955	CcSEcCtD
Tizanidine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000954	CcSEcCtD
Tizanidine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000954	CcSEcCtD
Tizanidine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000134	0.000951	CcSEcCtD
Tizanidine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000134	0.00095	CcSEcCtD
Tizanidine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000947	CcSEcCtD
Tizanidine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000946	CcSEcCtD
Tizanidine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000946	CcSEcCtD
Tizanidine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000942	CcSEcCtD
Tizanidine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000133	0.00094	CcSEcCtD
Tizanidine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000133	0.000939	CcSEcCtD
Tizanidine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.000939	CcSEcCtD
Tizanidine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000934	CcSEcCtD
Tizanidine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.000927	CcSEcCtD
Tizanidine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00013	0.000919	CcSEcCtD
Tizanidine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000919	CcSEcCtD
Tizanidine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.000912	CcSEcCtD
Tizanidine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000129	0.000912	CcSEcCtD
Tizanidine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.000907	CcSEcCtD
Tizanidine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000128	0.000907	CcSEcCtD
Tizanidine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000128	0.000907	CcSEcCtD
Tizanidine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.000907	CcSEcCtD
Tizanidine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000905	CcSEcCtD
Tizanidine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.000904	CcSEcCtD
Tizanidine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000898	CcSEcCtD
Tizanidine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.000897	CcSEcCtD
Tizanidine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000126	0.000896	CcSEcCtD
Tizanidine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000126	0.000896	CcSEcCtD
Tizanidine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000126	0.000893	CcSEcCtD
Tizanidine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.000893	CcSEcCtD
Tizanidine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000891	CcSEcCtD
Tizanidine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000889	CcSEcCtD
Tizanidine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000889	CcSEcCtD
Tizanidine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.000886	CcSEcCtD
Tizanidine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.000879	CcSEcCtD
Tizanidine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.000875	CcSEcCtD
Tizanidine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000874	CcSEcCtD
Tizanidine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000871	CcSEcCtD
Tizanidine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000861	CcSEcCtD
Tizanidine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000857	CcSEcCtD
Tizanidine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000857	CcSEcCtD
Tizanidine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000119	0.000846	CcSEcCtD
Tizanidine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.000846	CcSEcCtD
Tizanidine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000119	0.000845	CcSEcCtD
Tizanidine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000842	CcSEcCtD
Tizanidine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000836	CcSEcCtD
Tizanidine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000828	CcSEcCtD
Tizanidine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000824	CcSEcCtD
Tizanidine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000824	CcSEcCtD
Tizanidine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000115	0.000812	CcSEcCtD
Tizanidine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.000812	CcSEcCtD
Tizanidine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000811	CcSEcCtD
Tizanidine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000811	CcSEcCtD
Tizanidine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000807	CcSEcCtD
Tizanidine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000798	CcSEcCtD
Tizanidine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000112	0.000795	CcSEcCtD
Tizanidine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000785	CcSEcCtD
Tizanidine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000785	CcSEcCtD
Tizanidine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000782	CcSEcCtD
Tizanidine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000778	CcSEcCtD
Tizanidine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000769	CcSEcCtD
Tizanidine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000767	CcSEcCtD
Tizanidine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000759	CcSEcCtD
Tizanidine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000759	CcSEcCtD
Tizanidine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000743	CcSEcCtD
Tizanidine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000742	CcSEcCtD
Tizanidine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00073	CcSEcCtD
Tizanidine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00073	CcSEcCtD
Tizanidine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000724	CcSEcCtD
Tizanidine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000724	CcSEcCtD
Tizanidine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000723	CcSEcCtD
Tizanidine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000723	CcSEcCtD
Tizanidine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000719	CcSEcCtD
Tizanidine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000718	CcSEcCtD
Tizanidine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000717	CcSEcCtD
Tizanidine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000717	CcSEcCtD
Tizanidine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000715	CcSEcCtD
Tizanidine—Rash—Montelukast—chronic obstructive pulmonary disease	0.0001	0.000709	CcSEcCtD
Tizanidine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0001	0.000708	CcSEcCtD
Tizanidine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	9.98e-05	0.000707	CcSEcCtD
Tizanidine—Depression—Prednisone—chronic obstructive pulmonary disease	9.97e-05	0.000706	CcSEcCtD
Tizanidine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	9.86e-05	0.000698	CcSEcCtD
Tizanidine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	9.8e-05	0.000694	CcSEcCtD
Tizanidine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	9.8e-05	0.000694	CcSEcCtD
Tizanidine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.73e-05	0.000689	CcSEcCtD
Tizanidine—Malaise—Prednisolone—chronic obstructive pulmonary disease	9.7e-05	0.000687	CcSEcCtD
Tizanidine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.66e-05	0.000684	CcSEcCtD
Tizanidine—Rash—Salbutamol—chronic obstructive pulmonary disease	9.65e-05	0.000683	CcSEcCtD
Tizanidine—Syncope—Prednisolone—chronic obstructive pulmonary disease	9.64e-05	0.000683	CcSEcCtD
Tizanidine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.64e-05	0.000683	CcSEcCtD
Tizanidine—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.63e-05	0.000682	CcSEcCtD
Tizanidine—Nausea—Formoterol—chronic obstructive pulmonary disease	9.63e-05	0.000682	CcSEcCtD
Tizanidine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	9.45e-05	0.000669	CcSEcCtD
Tizanidine—Nausea—Montelukast—chronic obstructive pulmonary disease	9.43e-05	0.000668	CcSEcCtD
Tizanidine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	9.32e-05	0.00066	CcSEcCtD
Tizanidine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.28e-05	0.000658	CcSEcCtD
Tizanidine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	9.14e-05	0.000647	CcSEcCtD
Tizanidine—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.09e-05	0.000644	CcSEcCtD
Tizanidine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	9.05e-05	0.000641	CcSEcCtD
Tizanidine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	9.02e-05	0.000639	CcSEcCtD
Tizanidine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	8.98e-05	0.000636	CcSEcCtD
Tizanidine—Hallucination—Prednisone—chronic obstructive pulmonary disease	8.93e-05	0.000633	CcSEcCtD
Tizanidine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	8.82e-05	0.000625	CcSEcCtD
Tizanidine—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.78e-05	0.000622	CcSEcCtD
Tizanidine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.78e-05	0.000622	CcSEcCtD
Tizanidine—Shock—Prednisolone—chronic obstructive pulmonary disease	8.63e-05	0.000612	CcSEcCtD
Tizanidine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.57e-05	0.000607	CcSEcCtD
Tizanidine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.48e-05	0.000601	CcSEcCtD
Tizanidine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	8.14e-05	0.000577	CcSEcCtD
Tizanidine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	8.11e-05	0.000574	CcSEcCtD
Tizanidine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	8.02e-05	0.000568	CcSEcCtD
Tizanidine—Alopecia—Prednisone—chronic obstructive pulmonary disease	7.93e-05	0.000562	CcSEcCtD
Tizanidine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.88e-05	0.000558	CcSEcCtD
Tizanidine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.000557	CcSEcCtD
Tizanidine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	7.36e-05	0.000522	CcSEcCtD
Tizanidine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.25e-05	0.000514	CcSEcCtD
Tizanidine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.23e-05	0.000512	CcSEcCtD
Tizanidine—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.22e-05	0.000512	CcSEcCtD
Tizanidine—Agitation—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.000509	CcSEcCtD
Tizanidine—Malaise—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000499	CcSEcCtD
Tizanidine—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.02e-05	0.000497	CcSEcCtD
Tizanidine—Syncope—Prednisone—chronic obstructive pulmonary disease	7.01e-05	0.000496	CcSEcCtD
Tizanidine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.97e-05	0.000494	CcSEcCtD
Tizanidine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.87e-05	0.000486	CcSEcCtD
Tizanidine—Convulsion—Prednisone—chronic obstructive pulmonary disease	6.77e-05	0.00048	CcSEcCtD
Tizanidine—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.75e-05	0.000478	CcSEcCtD
Tizanidine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.65e-05	0.000471	CcSEcCtD
Tizanidine—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.63e-05	0.00047	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	6.61e-05	0.000468	CcSEcCtD
Tizanidine—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.000466	CcSEcCtD
Tizanidine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.47e-05	0.000458	CcSEcCtD
Tizanidine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.38e-05	0.000452	CcSEcCtD
Tizanidine—Oedema—Prednisone—chronic obstructive pulmonary disease	6.38e-05	0.000452	CcSEcCtD
Tizanidine—Infection—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000449	CcSEcCtD
Tizanidine—Shock—Prednisone—chronic obstructive pulmonary disease	6.27e-05	0.000444	CcSEcCtD
Tizanidine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.000443	CcSEcCtD
Tizanidine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.22e-05	0.000441	CcSEcCtD
Tizanidine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.19e-05	0.000439	CcSEcCtD
Tizanidine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.17e-05	0.000437	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000412	CcSEcCtD
Tizanidine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.8e-05	0.000411	CcSEcCtD
Tizanidine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.73e-05	0.000406	CcSEcCtD
Tizanidine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.61e-05	0.000398	CcSEcCtD
Tizanidine—Rash—Prednisolone—chronic obstructive pulmonary disease	5.53e-05	0.000392	CcSEcCtD
Tizanidine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.53e-05	0.000392	CcSEcCtD
Tizanidine—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000389	CcSEcCtD
Tizanidine—Constipation—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.000386	CcSEcCtD
Tizanidine—ADRA2C—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	5.35e-05	0.00283	CbGpPWpGaD
Tizanidine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.26e-05	0.000372	CcSEcCtD
Tizanidine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	5.24e-05	0.00277	CbGpPWpGaD
Tizanidine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.000369	CcSEcCtD
Tizanidine—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.21e-05	0.000369	CcSEcCtD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	5.14e-05	0.00272	CbGpPWpGaD
Tizanidine—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.07e-05	0.000359	CcSEcCtD
Tizanidine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.04e-05	0.000357	CcSEcCtD
Tizanidine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.04e-05	0.000357	CcSEcCtD
Tizanidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.03e-05	0.00266	CbGpPWpGaD
Tizanidine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	4.81e-05	0.00255	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.81e-05	0.00255	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—APIP—chronic obstructive pulmonary disease	4.79e-05	0.00254	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	4.72e-05	0.0025	CbGpPWpGaD
Tizanidine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.7e-05	0.000333	CcSEcCtD
Tizanidine—ADRA2B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.69e-05	0.00248	CbGpPWpGaD
Tizanidine—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.58e-05	0.000324	CcSEcCtD
Tizanidine—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.51e-05	0.00032	CcSEcCtD
Tizanidine—ADRA2C—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.5e-05	0.00238	CbGpPWpGaD
Tizanidine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.42e-05	0.00234	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	4.4e-05	0.00233	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.38e-05	0.00232	CbGpPWpGaD
Tizanidine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.37e-05	0.00231	CbGpPWpGaD
Tizanidine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.36e-05	0.000309	CcSEcCtD
Tizanidine—ADRA2A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	4.34e-05	0.0023	CbGpPWpGaD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.3e-05	0.00228	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.24e-05	0.00225	CbGpPWpGaD
Tizanidine—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.22e-05	0.000299	CcSEcCtD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.21e-05	0.00223	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	4.18e-05	0.00221	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TGFB2—chronic obstructive pulmonary disease	4.17e-05	0.00221	CbGpPWpGaD
Tizanidine—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.06e-05	0.000287	CcSEcCtD
Tizanidine—Rash—Prednisone—chronic obstructive pulmonary disease	4.02e-05	0.000285	CcSEcCtD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.02e-05	0.00213	CbGpPWpGaD
Tizanidine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.02e-05	0.000285	CcSEcCtD
Tizanidine—ADRA2B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.01e-05	0.00212	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.94e-05	0.00208	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.9e-05	0.00206	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APIP—chronic obstructive pulmonary disease	3.89e-05	0.00206	CbGpPWpGaD
Tizanidine—Nausea—Prednisone—chronic obstructive pulmonary disease	3.79e-05	0.000268	CcSEcCtD
Tizanidine—ADRA2C—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.75e-05	0.00198	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.74e-05	0.00198	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.69e-05	0.00195	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	3.65e-05	0.00193	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.64e-05	0.00193	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	3.59e-05	0.0019	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.59e-05	0.0019	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	3.58e-05	0.00189	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	3.56e-05	0.00188	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.55e-05	0.00188	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	3.55e-05	0.00188	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.5e-05	0.00185	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.44e-05	0.00182	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.4e-05	0.0018	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.37e-05	0.00179	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.35e-05	0.00178	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.32e-05	0.00176	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	3.31e-05	0.00175	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.3e-05	0.00175	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.26e-05	0.00173	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.23e-05	0.00171	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.23e-05	0.00171	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.23e-05	0.00171	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.21e-05	0.0017	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.2e-05	0.00169	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.17e-05	0.00168	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.17e-05	0.00168	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.15e-05	0.00167	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.11e-05	0.00165	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GC—chronic obstructive pulmonary disease	3.09e-05	0.00163	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.08e-05	0.00163	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.08e-05	0.00163	CbGpPWpGaD
Tizanidine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.06e-05	0.00162	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.04e-05	0.00161	CbGpPWpGaD
Tizanidine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.02e-05	0.0016	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.02e-05	0.0016	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3e-05	0.00159	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.94e-05	0.00156	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.87e-05	0.00152	CbGpPWpGaD
Tizanidine—ADRA2B—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.86e-05	0.00152	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.84e-05	0.0015	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.84e-05	0.0015	CbGpPWpGaD
Tizanidine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.82e-05	0.00149	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.81e-05	0.00149	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.8e-05	0.00148	CbGpPWpGaD
Tizanidine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.78e-05	0.00147	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.76e-05	0.00146	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.74e-05	0.00145	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.72e-05	0.00144	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.7e-05	0.00143	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	2.69e-05	0.00142	CbGpPWpGaD
Tizanidine—ADRA2C—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.68e-05	0.00142	CbGpPWpGaD
Tizanidine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.67e-05	0.00141	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.65e-05	0.0014	CbGpPWpGaD
Tizanidine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.63e-05	0.00139	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.62e-05	0.00139	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.58e-05	0.00136	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.56e-05	0.00136	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GC—chronic obstructive pulmonary disease	2.51e-05	0.00133	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.45e-05	0.0013	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.44e-05	0.00129	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.43e-05	0.00129	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.41e-05	0.00128	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.37e-05	0.00125	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.33e-05	0.00123	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.28e-05	0.00121	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.28e-05	0.00121	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.25e-05	0.00119	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.24e-05	0.00119	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.23e-05	0.00118	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.21e-05	0.00117	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.17e-05	0.00115	CbGpPWpGaD
Tizanidine—ADRA2A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.17e-05	0.00115	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.16e-05	0.00114	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.15e-05	0.00114	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.15e-05	0.00114	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.13e-05	0.00113	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.13e-05	0.00113	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.09e-05	0.00111	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.03e-05	0.00108	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.03e-05	0.00107	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.01e-05	0.00106	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.9e-05	0.001	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.85e-05	0.000982	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.84e-05	0.000976	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.83e-05	0.00097	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.83e-05	0.000969	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—ALB—chronic obstructive pulmonary disease	1.83e-05	0.000968	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.81e-05	0.00096	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.8e-05	0.000951	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.75e-05	0.000926	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.74e-05	0.000919	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.73e-05	0.000918	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.73e-05	0.000915	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.72e-05	0.000911	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.71e-05	0.000906	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—ALB—chronic obstructive pulmonary disease	1.71e-05	0.000904	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.7e-05	0.000901	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.69e-05	0.000897	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.69e-05	0.000893	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GCLC—chronic obstructive pulmonary disease	1.67e-05	0.000883	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.65e-05	0.000874	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.65e-05	0.000872	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.63e-05	0.000865	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.63e-05	0.000865	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.62e-05	0.000858	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.62e-05	0.000858	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.59e-05	0.00084	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.54e-05	0.000815	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.54e-05	0.000814	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.53e-05	0.000811	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CTGF—chronic obstructive pulmonary disease	1.52e-05	0.000805	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.48e-05	0.000785	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.44e-05	0.000763	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.42e-05	0.000753	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.4e-05	0.000742	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.4e-05	0.00074	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.39e-05	0.000736	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	1.39e-05	0.000734	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.38e-05	0.000733	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.38e-05	0.000728	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.37e-05	0.000725	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	1.35e-05	0.000717	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.35e-05	0.000712	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.33e-05	0.000702	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.32e-05	0.000697	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.32e-05	0.000697	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.29e-05	0.000681	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.27e-05	0.000672	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.26e-05	0.000667	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.25e-05	0.000662	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	1.24e-05	0.000654	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.2e-05	0.000637	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.19e-05	0.000628	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.18e-05	0.000625	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.18e-05	0.000623	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.17e-05	0.000619	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.16e-05	0.000612	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.00061	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.14e-05	0.000603	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.1e-05	0.000583	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.09e-05	0.000579	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.09e-05	0.000576	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.08e-05	0.000572	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.07e-05	0.000569	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.03e-05	0.000543	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.000539	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.02e-05	0.000538	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.8e-06	0.000519	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.73e-06	0.000515	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.63e-06	0.00051	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	9.56e-06	0.000506	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	9.52e-06	0.000504	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.49e-06	0.000503	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.36e-06	0.000496	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.15e-06	0.000485	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.09e-06	0.000481	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.95e-06	0.000474	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.9e-06	0.000471	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TP53—chronic obstructive pulmonary disease	8.89e-06	0.000471	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.84e-06	0.000468	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	8.77e-06	0.000464	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.72e-06	0.000462	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.51e-06	0.000451	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.31e-06	0.00044	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.27e-06	0.000438	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.26e-06	0.000437	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.26e-06	0.000437	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.95e-06	0.000421	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.91e-06	0.000419	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.56e-06	0.0004	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.47e-06	0.000396	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.44e-06	0.000394	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.39e-06	0.000391	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.38e-06	0.000391	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	7.22e-06	0.000382	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.97e-06	0.000369	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	6.92e-06	0.000366	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.82e-06	0.000361	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.75e-06	0.000358	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.71e-06	0.000355	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	6.62e-06	0.000351	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.5e-06	0.000344	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.46e-06	0.000342	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.21e-06	0.000329	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.08e-06	0.000322	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6e-06	0.000318	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.93e-06	0.000314	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.8e-06	0.000307	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	5.62e-06	0.000298	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.54e-06	0.000293	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	5.38e-06	0.000285	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.26e-06	0.000278	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.24e-06	0.000277	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.17e-06	0.000274	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5e-06	0.000265	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.94e-06	0.000261	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.91e-06	0.00026	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.82e-06	0.000255	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.76e-06	0.000252	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.71e-06	0.000249	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.67e-06	0.000247	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.57e-06	0.000242	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.5e-06	0.000238	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.44e-06	0.000235	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.27e-06	0.000226	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.99e-06	0.000211	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.99e-06	0.000211	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.92e-06	0.000208	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.84e-06	0.000203	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.79e-06	0.000201	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.66e-06	0.000194	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.61e-06	0.000191	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.59e-06	0.00019	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.24e-06	0.000172	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.23e-06	0.000171	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.1e-06	0.000164	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.01e-06	0.00016	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.97e-06	0.000157	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.97e-06	0.000157	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.95e-06	0.000156	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.92e-06	0.000154	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.76e-06	0.000146	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.45e-06	0.00013	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.24e-06	0.000119	CbGpPWpGaD
